Ph1 Positive CML
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS (NCT01159028) | Bio-Path Holdings, Inc. | 2010-06-01 |
Track Ph1 Positive CML automatically
Every clearance here is in the API, with alerts when new ones post.